X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12410) 12410
Newsletter (122) 122
Magazine Article (67) 67
Book Chapter (17) 17
Book Review (9) 9
Publication (6) 6
Book / eBook (4) 4
Dissertation (3) 3
Newspaper Article (3) 3
Conference Proceeding (2) 2
Reference (2) 2
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11009) 11009
bronchodilator agents - administration & dosage (7569) 7569
male (6456) 6456
female (5909) 5909
administration, inhalation (4940) 4940
bronchodilator agents - therapeutic use (4762) 4762
asthma - drug therapy (4658) 4658
adult (3724) 3724
middle aged (3717) 3717
respiratory system (3593) 3593
asthma (3260) 3260
aged (2663) 2663
pulmonary disease, chronic obstructive - drug therapy (2277) 2277
treatment outcome (2095) 2095
albuterol - administration & dosage (2042) 2042
child (2028) 2028
double-blind method (1948) 1948
adolescent (1918) 1918
nebulizers and vaporizers (1864) 1864
bronchodilator agents - adverse effects (1711) 1711
pharmacology & pharmacy (1596) 1596
asthma - physiopathology (1517) 1517
bronchodilator agents - pharmacology (1449) 1449
drug therapy, combination (1426) 1426
aerosols (1361) 1361
copd (1257) 1257
animals (1237) 1237
drug therapy (1232) 1232
lung diseases, obstructive (1156) 1156
child, preschool (1142) 1142
albuterol - therapeutic use (1131) 1131
chronic obstructive pulmonary disease (1122) 1122
bronchodilator agents (1115) 1115
pulmonary disease, chronic obstructive - physiopathology (1101) 1101
time factors (1095) 1095
dose-response relationship, drug (1089) 1089
obstructive pulmonary-disease (1080) 1080
forced expiratory volume (1026) 1026
forced expiratory volume - drug effects (1001) 1001
children (997) 997
salmeterol (943) 943
medicine, general & internal (935) 935
care and treatment (932) 932
pediatrics (926) 926
budesonide (925) 925
respiratory function tests (922) 922
adrenergic beta-agonists - administration & dosage (893) 893
adrenal cortex hormones - administration & dosage (874) 874
allergy (869) 869
severity of illness index (868) 868
cross-over studies (853) 853
corticosteroids (851) 851
fluticasone (840) 840
salbutamol (839) 839
albuterol - analogs & derivatives (837) 837
spirometry (814) 814
infant (805) 805
adrenal cortex hormones - therapeutic use (791) 791
salmeterol xinafoate (778) 778
dosage and administration (776) 776
drug administration schedule (773) 773
research (754) 754
drug combinations (752) 752
adrenergic beta-agonists - therapeutic use (743) 743
budesonide - administration & dosage (741) 741
albuterol (740) 740
formoterol fumarate (720) 720
critical care medicine (712) 712
efficacy (707) 707
bronchodilators (701) 701
therapy (696) 696
tiotropium (694) 694
bronchodilator agents - pharmacokinetics (688) 688
administration, oral (677) 677
lung - drug effects (660) 660
formoterol (655) 655
pulmonary disease, chronic obstructive - diagnosis (649) 649
ethanolamines - administration & dosage (627) 627
lung - physiopathology (622) 622
asthma - diagnosis (620) 620
anti-asthmatic agents - administration & dosage (611) 611
analysis (610) 610
androstadienes - administration & dosage (608) 608
immunology (601) 601
prospective studies (597) 597
risk factors (597) 597
management (594) 594
acute disease (593) 593
health aspects (577) 577
cardiac & cardiovascular systems (573) 573
inhaled corticosteroids (569) 569
bronchodilator (562) 562
quality of life (558) 558
aged, 80 and over (549) 549
safety (546) 546
respiratory tract diseases (535) 535
lung diseases, obstructive - drug therapy (532) 532
theophylline - administration & dosage (526) 526
pulmonary/respiratory (522) 522
inhalation (502) 502
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11512) 11512
German (356) 356
French (245) 245
Japanese (170) 170
Russian (155) 155
Spanish (123) 123
Polish (63) 63
Italian (53) 53
Danish (51) 51
Chinese (48) 48
Portuguese (36) 36
Dutch (35) 35
Norwegian (26) 26
Swedish (25) 25
Romanian (20) 20
Czech (14) 14
Turkish (10) 10
Hungarian (8) 8
Bulgarian (6) 6
Hebrew (6) 6
Finnish (3) 3
Lithuanian (3) 3
Serbian (2) 2
Slovak (2) 2
Croatian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 20, pp. 1865 - 1876
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 20, pp. 1877 - 1887
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 10/2004, Volume 170, Issue 8, pp. 836 - 844
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2008, Volume 122, Issue 6, pp. 1138 - 1144.e4
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9766, pp. 650 - 657
Journal Article
Thorax, ISSN 0040-6376, 02/2014, Volume 69, Issue 2, pp. 130 - 136
Background In mild asthma exercise-induced bronchoconstriction (EIB) is usually treated with inhaled short-acting β2 agonists (SABAs) on demand. Objective The... 
BECLOMETHASONE | MAINTENANCE | RESPIRATORY SYSTEM | TOLERANCE | RELIEVER THERAPY | BUDESONIDE | METHACHOLINE | INDUCED BRONCHOSPASM | BETA-AGONISTS | CHILDREN | SALMETEROL | Bronchodilator Agents - therapeutic use | Terbutaline - adverse effects | Ethanolamines - adverse effects | Formoterol Fumarate | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Terbutaline - therapeutic use | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Asthma, Exercise-Induced - physiopathology | Humans | Male | Ethanolamines - administration & dosage | Vital Capacity - drug effects | Young Adult | Terbutaline - administration & dosage | Adrenergic beta-2 Receptor Agonists - adverse effects | Exercise Test - methods | Adrenergic beta-2 Receptor Agonists - therapeutic use | Adult | Female | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Glucocorticoids - adverse effects | Double-Blind Method | Drug Administration Schedule | Administration, Inhalation | Asthma, Exercise-Induced - prevention & control | Budesonide - adverse effects | Budesonide - therapeutic use | Adolescent | Adrenergic beta-2 Receptor Agonists - administration & dosage | Ethanolamines - therapeutic use | Budesonide - administration & dosage | Budesonide | Formoterol | Dosage and administration | Research | Drug therapy, Combination | Drug therapy | Asthma | Exercise | Fitness equipment | Steroids | 1506 | Clinical Medicine | Lungmedicin och allergi | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Respiratory Medicine and Allergy
Journal Article
Journal of cystic fibrosis, ISSN 1569-1993, 2009, Volume 8, Issue 5, pp. 295 - 315
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 18, pp. 1671 - 1680
The frequency of COPD exacerbations during treatment with a triple inhaler — delivering a long-acting beta-agonist (LABA), a long-acting muscarinic antagonist... 
MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | IMPACT | PARALLEL-GROUP | DOUBLE-BLIND | TIOTROPIUM | RANDOMIZED CONTROLLED-TRIAL | FLUTICASONE PROPIONATE/SALMETEROL | SALMETEROL | Glucocorticoids - administration & dosage | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Benzyl Alcohols - administration & dosage | Hospitalization - statistics & numerical data | Male | Dyspnea - etiology | Quinuclidines - administration & dosage | Chlorobenzenes - administration & dosage | Adrenergic beta-Agonists - administration & dosage | Adult | Female | Bronchodilator Agents - adverse effects | Adrenergic beta-Agonists - adverse effects | Glucocorticoids - adverse effects | Double-Blind Method | Drug Administration Schedule | Administration, Inhalation | Pulmonary Disease, Chronic Obstructive - complications | Muscarinic Antagonists - administration & dosage | Androstadienes - administration & dosage | Intention to Treat Analysis | Quality of Life | Dyspnea - drug therapy | Aged | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Treatment outcome | Lung diseases, Obstructive | Care and treatment | Usage | Analysis | Diagnosis | Inhalers | Pneumonia | Acetylcholine receptors (muscarinic) | Glucocorticoids | Lung diseases | Critical care | Fluticasone | Patients | Quality of life | Medicine | Hospitals | Obstructive lung disease | Population | Chronic obstructive pulmonary disease | Drug dosages | Life Sciences | Human health and pathology | Pulmonology and respiratory tract
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2010, Volume 2010, Issue 5, p. CD005535
Background Long‐acting inhaled ß2‐adrenergic agonists (LABAs) are recommended as 'add‐on' medication to inhaled corticosteroids (ICS) in the maintenance... 
Formoterol Fumarate | Lungs & airways | Adrenal Cortex Hormones | Asthma (chronic): bronchodilators | Anti‐Asthmatic Agents | Combination and additive therapies | Beclomethasone | Asthma (chronic) | Child health | Bronchodilators | Asthma, chronic ‐ pharmacotherapy | Albuterol | Drug Therapy, Combination | Asthma (chronic): combination/additive drug treatment | Salmeterol Xinafoate | Administration, Inhalation | Ethanolamines | Asthma | Randomized Controlled Trials as Topic | Steroids, inhaled | Beta‐agonists, long‐acting | Adrenergic beta‐Agonists | Medicine General & Introductory Medical Sciences | Chronic Disease | Combination/additive drug treatment | Adrenal Cortex Hormones [therapeutic use] | COST-EFFECTIVENESS ANALYSIS | Humans | Adrenergic beta-Agonists [therapeutic use] | SURROGATE INFLAMMATORY MARKERS | MEDICINE, GENERAL & INTERNAL | FLUTICASONE PROPIONATE/SALMETEROL COMBINATION | LEUKOTRIENE RECEPTOR ANTAGONIST | Asthma [drug therapy] | Adult | TWICE-DAILY TREATMENT | SALMETEROL/FLUTICASONE PROPIONATE COMBINATION | FORMOTEROL OXIS(R) TURBUHALER(R) | QUALITY-OF-LIFE | MILD PERSISTENT ASTHMA | Child | Anti-Asthmatic Agents [therapeutic use] | ONCE-DAILY BUDESONIDE | Beclomethasone - administration & dosage | Albuterol - analogs & derivatives | Child, Preschool | Asthma - drug therapy | Ethanolamines - administration & dosage | Drug Therapy, Combination - methods | Adolescent | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Anti-Asthmatic Agents - administration & dosage | Adrenal Cortex Hormones - administration & dosage
Journal Article